A

Aegis Ventures

Launches AI-driven health tech companies

Product Operations and Support Specialist

Full-Time
No salary listed
Mid
Remote in USA
Remote
Customer Experience & SupportCustomer Support

About the job

Requirements
  • At least 3 years of experience in technical support, product support, application support, or product operations for software as a medical device or a combined hardware-software medical device product.
  • Ability to troubleshoot across hardware-software boundaries and isolate whether problems originate in a hardware device, software, image quality, connectivity, or user technique; ability to reproduce issues occurring on equipment at a remote customer site.
  • Familiarity with quality management systems and complaint-handling processes in a regulated environment, including FDA 21 CFR 820/QMSR, ISO 13485, or EU MDR, and understanding when an issue may be a reportable complaint or adverse event.
  • Strong written communication and experience building knowledge base articles, runbooks, or training that enables less-technical teammates to resolve issues independently.
  • Ability to explain technical concepts clearly to non-technical users.
  • Operational initiative and project ownership experience, including gathering requirements for internal tools or processes, prioritizing competing work, and driving cross-functional projects to completion with minimal oversight in a remote team setting.
Responsibilities
  • Serve as Tier 2 support for customers who escalate device feedback, complaints, and semi-technical product issues by reproducing, diagnosing, and resolving problems across the hardware-software boundary.
  • Distinguish camera or hardware faults from software, image-quality, connectivity, EHR-integration, or user-technique issues.
  • Capture, document, and route device feedback and complaints in line with Optain’s quality management system and applicable regulations.
  • Recognize when feedback may constitute a reportable complaint or potential adverse event and escalate appropriately to Quality and Regulatory.
  • Support the Customer Success team with semi-technical product and onboarding questions as the bridge between front-line Customer Success and Engineering support.
  • Contribute to knowledge base articles, troubleshooting guides, and training resources that enable Customer Success to resolve more issues independently.
  • Own internal operations and projects for the product team, including specifying requirements for internal support tooling, improving support and complaint-handling workflows, and coordinating cross-functional projects from intake to delivery.
  • Support Quality in tracking and analyzing support and complaint trends.
  • Translate recurring problems into prioritized product improvement recommendations and serve as a voice of the customer within the product organization.
  • Partner with Product, Engineering, Quality, Regulatory, and Customer Success to ensure issues are resolved quickly while meeting the documentation rigor required of a regulated medical device.
Desired Qualifications
  • Experience with imaging medical devices, telemedicine, EHR integrations, or clinical workflows in a primary care or point-of-care setting.

About the company

Aegis Ventures is a startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale new companies focused on AI and health tech. It operates a platform that combines market-shaping ideas, permanent growth capital, and ambitious people to identify opportunities, fund them long-term, and provide hands-on operational support. Unlike traditional funds, it creates companies in-house with a built-in path to rapid growth, with a strong emphasis on transforming healthcare quality, access, and cost. Its goal is to build companies capable of vast impact by using technology to improve health outcomes and societal wellbeing.

Company Size

11-50

Company Stage

N/A

Total Funding

$33.1M

Headquarters

New York City, New York

Founded

2020

Get referred to Aegis Ventures

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Wavelet secured $7 million on April 14, 2026, and is piloting at Yale and USC.
  • Optain acquired EyePACS in November 2025 and now serves 200 provider sites globally.
  • Aegis added Bunny Ellerin on April 6, 2026 and published a medtech AI whitepaper.

What critics are saying

  • Wavelet’s fetal EEG needs regulatory clearance and obstetric adoption before proving commercial demand.
  • Optain’s teleophthalmology rollout depends on reimbursement, workflow integration, and specialist validation.
  • Aegis’ public sites conflict on healthtech versus blockchain messaging, confusing talent and investors.

What makes Aegis Ventures unique

  • Aegis launched six healthtech companies by May 2026, pairing studio building with permanent capital.
  • Northwell, Yale, and Aegis give portfolio companies immediate clinical sites and enterprise buyers.
  • Aegis targets AI-native healthcare workflows, biomarkers, consumer care, and real-world data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Flexible Work Hours
  • Company Equity
  • Wellness Program
  • Mental Health Support

Company News

Yahoo Finance
Apr 14th, 2026
Yale-born fetal brain monitoring startup Wavelet secures $7M to prevent birth injuries

Wavelet Medical has secured $7 million in seed funding from Aegis Ventures to commercialise the first non-invasive, AI-powered fetal electroencephalography monitoring platform. The technology, developed at Yale, aims to detect fetal brain distress in real time and prevent avoidable brain injury at birth. Founded by Liz Golden, Dr Emily Lee and Dr Jose Cortes-Briones, Wavelet uses EEG captured through the mother's abdomen and reconstructed with AI algorithms to identify neurological distress, addressing limitations of traditional fetal heart rate monitoring, which is indeterminate in up to 85% of births. The platform targets a significant problem: over 35,000 infants suffer birth-related brain injuries annually in the US alone. Wavelet's partnership with Aegis Ventures will accelerate product development, clinical adoption and commercialisation of the technology.

PR Newswire
Apr 14th, 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine

/PRNewswire/ -- A breakthrough in fetal brain monitoring developed at Yale is moving from laboratory discovery to global commercialization through a pivotal...

Teknovation.biz
Nov 25th, 2024
News & Notes | Foundersforge Joins Village Capital’S Resource Iii Program For Entrepreneur Support Organizations

From Knoxville: The Knoxville Technology Council is asking local business representatives to complete its latest KTech Pulse 2024 Survey. Noting that the organization wants to get the pulse of Knoxville-area... The post News Notes | FoundersForge joins Village Capitals Resource III Program for Entrepreneur Support Organizations appeared first on Teknovation.biz.

Aegis Ventures
Oct 10th, 2023
Our Focus

We are driven by the mission to build companies that solve society's greatest problems, informed by the belief that the nexus of profits and purpose will create a virtuous cycle of impact that moves the world forward.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si